Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,083 total articles
An NBT Bancorp Inc. director, Timothy E. Delaney, purchased 22,730 shares on January 28, 2026, for $42.97 per share, totaling $976708. The transaction raises his direct holdings to 74,615 shares. The company also reported a fourth-quarter 2025 earnings beat and promoted Gina Rossi to chief marketing officer.
Michael T. Smith, a director at Teledyne Technologies, sold 4,000 shares across two transactions on January 28 and 29, 2026, at $621 per share for proceeds of $2.48 million. The company also reported record fourth-quarter earnings and revenue, prompting analysts to raise price targets. Teledyne announced executive compensation decisions and board c…
Jessica M. Lehman, executive vice president and director of trust services at Muncy Columbia Financial Corp, bought 100 shares of the company's common stock on January 28, 2026, at $60.00 per share, increasing her direct stake to 238 shares. The company has also declared a modestly higher quarterly cash dividend of $0.45 per share for Q4 2025, paya…
Parke Bancorp director Daniel J. Dalton reported the sale of 5,000 common shares on January 27, 2026, and the exercise of options to acquire 10,000 shares across January 27 and 28, 2026. The transactions and a separate dividend declaration were disclosed in SEC filings and company announcements; the bank is trading near $27 per share with a trailin…
Thomas Edward Gensemer, Chief Strategy Officer at Public Policy Holding Company (NASDAQ:PPHC), sold 2,484 shares on January 27, 2026 for $12.25 each, netting $30,429. The sale occurred as PPHC shares have dropped more than 15% over the prior week and trade at $12.00. InvestingPro analysis describes the stock as appearing undervalued versus its Fair…
Byline Bancorp director Phillip R. Cabrera acquired 169 shares of the company's common stock on January 28, 2026, for $31.03 per share, a total of $5,244. The purchase increases his direct holdings to 15,871 shares, with an additional 4,129 shares held indirectly through a revocable trust. The transaction comes after Byline reported fourth-quarter …
Saba Capital Management, L.P., a roughly ten-percent holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold 189,880 shares of common stock in two transactions on January 27 and January 28, 2026, for a combined $2.95 million. The trades priced between $15.53 and $15.54 per share. After the sales, Saba’s position decreased to 25,4…
Rajiv Kumar, Chief Accounting Officer of Priority Technology Holdings, sold 10,000 shares of the company's common stock on August 21, 2025, at $8.00 per share, generating $80,000 in proceeds and leaving him with 46,074 shares. Separately, Chairman and CEO Thomas Priore has proposed a take-private transaction offering $6.00 to $6.15 per share for sh…
Anixa Biosciences director Arnold M. Baskies purchased 10,000 shares of common stock on January 28, 2026, for $3.04 per share, bringing his direct holdings to 135,000 shares. The transaction coincides with recent clinical and intellectual property milestones for the company, even as the stock has pulled back in the past week and trades above a repo…
Stilwell Value LLC, affiliated funds and Joseph Stilwell disclosed a purchase of 618 shares of Peoples Financial Corp/MS/ (NASDAQ:PFBX) on January 28, 2026, at $20.5363 per share for a total of $12,691. The report outlines existing holdings across Stilwell-managed vehicles and notes valuation and financial-health metrics for the regional bank.
Norwood Financial Corp director James Shook purchased 3,500 shares of the company's common stock on January 28, 2026, spending $100,800 at $28.80 per share. Post-transaction, Shook holds 8,330 shares directly, plus indirect and restricted holdings. The company also reported significant fourth-quarter 2025 growth in net interest income and net incom…
Norwood Financial Corp director Joseph W. Carroll purchased 2,000 common shares at $27.91 apiece on January 27, 2026, a transaction valued at $55,820. After the buy, Carroll directly holds 37,503 shares and has additional indirect holdings attributed to family and retirement accounts. Separately, the company reported robust fourth-quarter 2025 resu…
Intuitive Surgical director Gary S. Guthart sold 27,300 shares on January 27, 2026, receiving $14,475,672, and on the same day exercised options to acquire 25,500 shares at $174.2567 per share. The trades were carried out under a pre-set SEC Rule 10b5-1 plan that expires April 28, 2026. The company reported robust fourth-quarter 2025 results with $…
Robert William Bennett, the former CEO and a director of Innovative Food Holdings INC (NASDAQ: IVFH), disposed of 1,971,340 shares of common stock between January 6 and January 21, 2026, realizing approximately $703,363. The transactions occurred at prices ranging from $0.30 to $0.47 per share. After the sales, Bennett holds 377,571 shares directly…
Coastal Financial Corp CFO Joel G Edwards sold 1,300 shares on January 26, 2026, raising $144,742 to cover withholding taxes related to restricted stock unit vesting. The stock has fallen since the sale and the company approaches an earnings release on February 3, 2026. Analysts maintain a bullish consensus and TD Cowen has raised its price target.
Timothy William Miller, Giftify's Vice President of Sales, disposed of $4,270 worth of company stock via four scheduled transactions between October 2025 and January 2026. The trades were carried out under a 10b5-1 plan set up with Merrill Lynch in February 2025. After the sales, Miller holds 42,833 shares of Giftify.
Robinhood Markets Chief Technology Officer Jeffrey Tsvi Pinner sold 6,264 shares of Class A common stock on January 26, 2026, generating roughly $630,283 in proceeds. The trades were carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 11, 2024. After the disposals, Pinner continues to directly hold 9,133 shares. The compan…
Mitsui Sumitomo Insurance Co., Ltd., identified as a roughly 10% holder of W.R. Berkley Corp (NYSE: WRB), completed multiple purchases of Berkley common stock totaling $69,297,689 over January 26-28, 2026. The transactions were executed under a Rule 10b5-1 plan adopted October 3, 2025, and pushed the insurer’s direct holdings to 55,618,435 shares. …
Crexendo Chief Financial Officer Ron Vincent sold 1,011 shares on January 22 for $7.784 per share, totaling $7,869, and completed additional share-withholdings and RSU exercises on January 25. The transactions were reported in a Form 4/A filing and leave Vincent with 172,635 direct shares. The company recently reported a 12% year-over-year increase…
Harmony Biosciences Holdings' Chief Financial Officer, Sandip Kapadia, sold 3,746 shares on January 26, 2026, for $139,171 under a Rule 10b5-1 trading plan. The company reported preliminary unaudited WAKIX net product revenue of roughly $243 million for Q4 2025 and $868 million for the full year, a 21% increase versus 2024, and issued a 2026 WAKIX …
National Services, Inc., a holder of roughly 10% of Usio, Inc. (NASDAQ: USIO), sold a total of 10,424 common shares on January 26-27, 2026, for about $14,103. The transactions left the shareholder with 2,749,616 shares after the second sale. Usio has reported steady third-quarter 2025 revenue, a decline in adjusted EBITDA, an increased cash balance…
Acumen Pharmaceuticals' Chief Legal Officer and Corporate Secretary, Derek M. Meisner, exercised options and then sold the resulting shares under a pre-set 10b5-1 plan on January 26 and January 28, 2026. The transactions involved 17,756 shares and generated proceeds of $53,279. Separately, Acumen reported a net loss for Q3 2025 and continued clinic…
Ewa Maria Stasiowska, Chief Risk Officer at Live Oak Bancshares (NASDAQ: LOB), purchased $99,999 of company stock on January 26, 2026. The acquisition coincides with robust fourth-quarter 2025 results and analyst optimism, while InvestingPro data indicates the shares may be trading below Fair Value with a low PEG ratio.
Michael Karanikolas, Co-Chief Executive Officer of Revolve Group, Inc. (NYSE:RVLV), sold 138,901 shares of Class A Common Stock between January 26 and January 28, 2026, through MMMK Development, Inc., generating about $4,039,936. The transactions coincided with a conversion of an equal number of Class B shares into Class A shares and leave Karaniko…
Michael Mente, Co-Chief Executive Officer of Revolve Group, Inc. (RVLV), sold 138,908 shares of Class A common stock between January 26 and January 28, 2026, for roughly $4,039,936. The transactions were carried out through MMMK Development, Inc. under a Rule 10b5-1 trading plan adopted May 29, 2025. Concurrently, Mente converted an identical numbe…
